These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 30855377)
1. Gender-specific risk factors for renal cell carcinoma: a systematic review. Lughezzani G; Paciotti M; Fasulo V; Casale P; Saita A Curr Opin Urol; 2019 May; 29(3):272-278. PubMed ID: 30855377 [TBL] [Abstract][Full Text] [Related]
2. Gender-Related Approach to Kidney Cancer Management: Moving Forward. Mancini M; Righetto M; Baggio G Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397685 [TBL] [Abstract][Full Text] [Related]
3. [A clinical study of 124 cases of renal cell carcinoma]. Homma Y; Sugimoto M; Minowada S; Higashihara E; Aso Y Nihon Hinyokika Gakkai Zasshi; 1990 May; 81(5):726-31. PubMed ID: 2376929 [TBL] [Abstract][Full Text] [Related]
4. Pathology, therapy and prognosis of papillary renal carcinoma. Fernandes DS; Lopes JM Future Oncol; 2015; 11(1):121-32. PubMed ID: 25572787 [TBL] [Abstract][Full Text] [Related]
7. Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy. Lam JS; Shvarts O; Leppert JT; Figlin RA; Belldegrun AS J Urol; 2005 Jun; 173(6):1853-62. PubMed ID: 15879764 [TBL] [Abstract][Full Text] [Related]
8. Detection, staging and clinical implications of renal cell carcinoma. Ghalayini IF; Bani-Hani IH Saudi Med J; 2003 Jan; 24(1):79-83. PubMed ID: 12590282 [TBL] [Abstract][Full Text] [Related]
9. Renal cell carcinoma: recent progress and future directions. Mulders P; Figlin R; deKernion JB; Wiltrout R; Linehan M; Parkinson D; deWolf W; Belldegrun A Cancer Res; 1997 Nov; 57(22):5189-95. PubMed ID: 9371523 [No Abstract] [Full Text] [Related]
10. Gender Differences in Incidence, Diagnosis, Treatments, and Outcomes in Clinically Localized Bladder and Renal Cancer. Gul ZG; Liaw CW; Mehrazin R Urology; 2021 May; 151():176-181. PubMed ID: 32561364 [TBL] [Abstract][Full Text] [Related]
11. Impact of gender in renal cell carcinoma: an analysis of the SEER database. Aron M; Nguyen MM; Stein RJ; Gill IS Eur Urol; 2008 Jul; 54(1):133-40. PubMed ID: 18160207 [TBL] [Abstract][Full Text] [Related]
12. [Hereditary renal tumors: More common than expected?]. Agaimy A; Hartmann A Pathologe; 2016 Mar; 37(2):134-43. PubMed ID: 26979427 [TBL] [Abstract][Full Text] [Related]
13. [Renal cell carcinoma in adults less than 40 years of age: a particular cancer? Incidence, outcome and review of the literature]. Rodriguez A; Tazi H; Patard JJ; Lobel B Ann Urol (Paris); 2003 Aug; 37(4):155-9. PubMed ID: 12951703 [TBL] [Abstract][Full Text] [Related]
17. Continued increase in incidence of renal cell carcinoma, especially in young patients and high grade disease: United States 2001 to 2010. King SC; Pollack LA; Li J; King JB; Master VA J Urol; 2014 Jun; 191(6):1665-70. PubMed ID: 24423441 [TBL] [Abstract][Full Text] [Related]
18. Age and gender related differences in renal cell carcinoma in a European cohort. Hew MN; Zonneveld R; Kümmerlin IP; Opondo D; de la Rosette JJ; Laguna MP J Urol; 2012 Jul; 188(1):33-8. PubMed ID: 22578731 [TBL] [Abstract][Full Text] [Related]
19. Characterizing changes in kidney and renal pelvis cancer incidence from 1998 to 2006 in the United States. Knox M; Colli JL Int Urol Nephrol; 2011 Jun; 43(2):359-63. PubMed ID: 20820915 [TBL] [Abstract][Full Text] [Related]
20. Chromophobe renal cell carcinoma: a review of an uncommon entity. Vera-Badillo FE; Conde E; Duran I Int J Urol; 2012 Oct; 19(10):894-900. PubMed ID: 22715810 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]